Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study.

Journal: The lancet. HIV

Publication Year: 2022

Authors & Co-authors:  Bekker Adrie A Capparelli Edmund V EV Violari Avy A Cotton Mark F MF Cababasay Mae M Wang Jiajia J Mathiba Ruth R Wiesner Lubbe L Wiznia Andrew A Samson Pearl P

Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.

Journal: The lancet. HIV

Publication Year: 2023

Authors & Co-authors:  Brooks Kiser Ziemba Ward Rani Cressey Masheto Cassim Deville Ponatshego